CORRESP Filing
Adagene Inc.
Date: May 28, 2025 · CIK: 0001818838 · Accession: 0001104659-25-053351
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287161
Letter
Adagene Inc.
4F, Building C14, No. 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu Province, 215123 People's Republic of China
May 28, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Chris Edwards
Mr. Tyler Howes
Ms. Laura Crotty
Re: Adagene Inc.
Registration Statement on Form F-3
Filed May 9, 2025
File No. 333-287161
Ladies and Gentlemen:
On behalf of Adagene Inc., (the "Company"), and pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the above-referenced Registration Statement on Form F-3 be accelerated so that it will be declared effective at 4:30 p.m. on May 30, 2025, or as soon thereafter as is practicable.
Please direct any questions regarding the foregoing to Xuelin (Steve) Wang at +852 2533-1092 (xuelin.wang@davispolk.com) of Davis Polk & Wardwell LLP, counsel to the Company.
Sincerely,
/s/ Peter Luo
Show Raw Text
CORRESP 1 filename1.htm Adagene Inc. 4F, Building C14, No. 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu Province, 215123 People's Republic of China May 28, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Chris Edwards Mr. Tyler Howes Ms. Laura Crotty Re: Adagene Inc. Registration Statement on Form F-3 Filed May 9, 2025 File No. 333-287161 Ladies and Gentlemen: On behalf of Adagene Inc., (the "Company"), and pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the above-referenced Registration Statement on Form F-3 be accelerated so that it will be declared effective at 4:30 p.m. on May 30, 2025, or as soon thereafter as is practicable. Please direct any questions regarding the foregoing to Xuelin (Steve) Wang at +852 2533-1092 (xuelin.wang@davispolk.com) of Davis Polk & Wardwell LLP, counsel to the Company. Sincerely, /s/ Peter Luo Peter Luo Chief Executive Officer Adagene Inc. cc: Xuelin (Steve) Wang, Esq.